TDOC — Teladoc Health Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual cashflow statement for Teladoc Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-429	-13,660	-220	-1,001	-200
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	427	13,659	221	959	171
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-50.3	-61	11.6	-36.3	1.07
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	194	189	350	294	294
Capital Expenditures	-63.9	-173	-156	-124	-157
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items	-9.05	5.02	0.001	0	-109
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-73	-168	-156	-124	-266
Financing Cash Flow Items	-0.73	-2.74	-0.278	-0.002	-4.11
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	40.9	6.5	10.9	8.31	-552
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	160	24.7	205	175	-517